We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+10.56%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$12.2B
AUM Growth
+$1.03B
Cap. Flow
+$49.2M
Cap. Flow %
0.4%
Top 10 Hldgs %
25.44%
Holding
2,628
New
63
Increased
565
Reduced
814
Closed
130

Top Buys

Rank Stock Value
1
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$379M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$14.1M
3
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$12.6M
4
EPAM icon
EPAM Systems
EPAM
+$8.07M
5
AA icon
Alcoa
AA
+$4.54M

Top Sells

Rank Stock Value
1
EPD icon
Enterprise Products Partners
EPD
+$31.9M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$31.2M
3
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$28.5M
4
MMP
Magellan Midstream Partners, L.P.
MMP
+$20.9M
5
AAPL icon
Apple
AAPL
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 22.34%
2 Healthcare 12.24%
3 Financials 12%
4 Consumer Discretionary 11.44%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALG icon
1476
Alamo Group
ALG
$1.99B
$527K ﹤0.01%
3,584
– –
HMN icon
1477
Horace Mann Educators
HMN
$2.1B
$526K ﹤0.01%
13,604
-2,071
-13% -$81.3K
GNL icon
1478
Global Net Lease
GNL
$1.9B
$526K ﹤0.01%
34,451
– –
PRO
1479
DELISTED
PROS Holdings
PRO
$526K ﹤0.01%
15,247
– –
VECO icon
1480
Veeco
VECO
$3.28B
$525K ﹤0.01%
18,456
– –
SUPN icon
1481
Supernus Pharmaceuticals
SUPN
$2.74B
$525K ﹤0.01%
17,997
– –
FCF icon
1482
First Commonwealth Financial
FCF
$2.19B
$522K ﹤0.01%
32,439
+4,284
+15% +$65K
VGR
1483
DELISTED
Vector Group Ltd.
VGR
$521K ﹤0.01%
45,412
-25,620
-36% -$274K
SYBT icon
1484
Stock Yards Bancorp
SYBT
$2.64B
$521K ﹤0.01%
8,157
– –
RWT
1485
Redwood Trust
RWT
$599M
$520K ﹤0.01%
39,416
– –
BBBY
1486
DELISTED
Bed Bath & Beyond Inc
BBBY
$519K ﹤0.01%
35,629
– –
AVAV icon
1487
AeroVironment
AVAV
$9.59B
$519K ﹤0.01%
8,365
– –
IMGN
1488
DELISTED
Immunogen Inc
IMGN
$518K ﹤0.01%
69,797
+10,556
+18% +$65.6K
PTGX icon
1489
Protagonist Therapeutics
PTGX
$9.8B
$516K ﹤0.01%
15,088
– –
LTC
1490
LTC Properties
LTC
$2.1B
$516K ﹤0.01%
15,108
– –
CERE
1491
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$515K ﹤0.01%
15,873
– –
ANAT
1492
DELISTED
American National Group, Inc. Common Stock
ANAT
$515K ﹤0.01%
2,725
– –
DVAX
1493
DELISTED
Dynavax Technologies
DVAX
$514K ﹤0.01%
36,559
– –
STRA icon
1494
Strategic Education
STRA
$1.86B
$514K ﹤0.01%
8,893
– –
TWOU
1495
DELISTED
2U Inc
TWOU
$514K ﹤0.01%
853
– –
CALM icon
1496
Cal-Maine
CALM
$3.87B
$514K ﹤0.01%
13,890
– –
FRG
1497
DELISTED
Franchise Group, Inc.
FRG
$512K ﹤0.01%
9,820
+775
+9% +$34.9K
LRN icon
1498
Stride
LRN
$3.48B
$511K ﹤0.01%
15,318
– –
TREE icon
1499
LendingTree
TREE
$461M
$510K ﹤0.01%
4,163
-5,501
-57% -$731K
ENTA icon
1500
Enanta Pharmaceuticals
ENTA
$391M
$510K ﹤0.01%
6,820
– –
58 59
60
61 62

Similar funds

Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

MetLife Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, MetLife Investment Management held 2,628 positions worth $12.2B, up 9.2% from $11.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management's Q4 2021 filing shows 63 new, 565 increased, 814 reduced and 130 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M. The largest sale was Enterprise Products Partners, an estimated $31.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q4 2021 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M.
  • MetLife Investment Management added most to iShares Russell 2000 ETF in Q4 2021, an estimated $14.1M increase.
  • MetLife Investment Management's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $31.2M.
  • MetLife Investment Management fully exited Enterprise Products Partners in Q4 2021, selling an estimated $31.9M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $12.2B portfolio in Q4 2021.
  • MetLife Investment Management opened 63 new positions and closed 130 in Q4 2021.
  • MetLife Investment Management's portfolio value rose 9.2% quarter-over-quarter to $12.2B.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.